AbCellera Biologics Inc 10-Q for FY2021 Q2
AbCellera Biologics Inc. (ABCL)
10-Q
2021-08-13
For: 2021-06-30
View Original
Added on
April 08, 2026
About this 10-Q
AbCellera Biologics Inc filed this 10-Q on August 13, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $27.64M
- up 146.2% from $11.23M a year earlier
- Net loss
- $2.32M
- compared with net income of $6.7M a year earlier
- Diluted EPS
- -$0.01
- compared with $0.03 a year earlier